Search for the latest oncology news by tumour type
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in…
Pheochromocytomas and paragangliomas are rare neuroendocrine tumours with a strong hereditary component. Half the genes…
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialised radiation…
By Ian Haines, Monash University From the 1980s, when prostate screening became available, many men…
Every day, four Australians are diagnosed with myelodysplastic syndrome (MDS), but many people’s resistance to…
The human body holds many mysteries, and function of the BRCA1 gene is among them.…
Poor diet is associated with 80% of colorectal cancer cases, but the exact pathways by…
Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20…
A personal cancer treatment vaccine that targets distinctive “neoantigens” on tumour cells has been shown…
The invention of the EPICUP epigenetic test last year allowed physicians to elucidate what type…